Industry
Global Hospital Acquired Infections Testing Kits Market to Reach USD 1.8 Billion by 2026
The global hospital acquired infections testing kits market is expected to grow at a CAGR of 12.7% from USD 1.12 billion in 2021 to USD 1.27 billion in 2022 and is projected to grow further at a CAGR of 8.8% to USD 1.78 billion in 2026, driven by increased incidence of chronic diseases. More...08 Apr 2022
Global Clinical Chemistry Analyzer Market Driven by Higher Testing Volume and Shorter TAT Due to Automation
In recent decades, the clinical chemistry instrumentation business has seen a rapid evolution of technological improvements. Novel features, such as closed tube sampling, automated maintenance processes, streamlined calibration, and internet-based remote diagnostics, have been introduced with each new system generation. These intend to help laboratories better meet the needs of physicians and patients while creating efficiencies, driving quality, lowering costs, and addressing workforce fluctuations. As a result, the global clinical chemistry analyzer market was valued at over USD 12 billion in 2021 and is anticipated to grow at a CAGR of 4.8% over the forecast period (2022-2030). More...28 Mar 2022
Roche and BMS Collaborate on Digital Pathology Algorithms and Cancer Diagnostic Assays
Advances in computation and artificial intelligence (AI) in digital pathology are showing promise to meet the demand for more accurate and comprehensive assessment of pathology results to enable improved patient outcomes. Roche (Basel, Switzerland; www.roche.com) has entered into a collaboration with Bristol Myers Squibb (BMY, New York, NY, USA) to support the advancement of two assays for use in clinical trials with the development and deployment of two new digital pathology algorithms. More...28 Mar 2022
AI-Powered Pathology to Drive Insight in Cancer Diagnosis
Driven by a growing base of evidence on the economic and clinical benefits of adoption, leading laboratories are increasingly looking to adopt AI in routine practice to optimize operations and improve patient care. A key barrier to deriving the full value of AI is the lab’s ability to seamlessly integrate this diverse range of applications into routine operations. Now, a strategic partnership will deliver integrated AI-enabled solutions that aim to improve clinical decision making for cancer care. More...25 Mar 2022
Siemens Enters Digital Pathology Market with Proscia’s Concentriq Dx Platform
Siemens Healthineers (Erlangen, Germany) and Proscia (Philadelphia, PA, USA) have entered into a multi-year OEM agreement under which Siemens will expand its Enterprise Imaging offering towards the global digital pathology market using Proscia’s Concentriq Dx platform. With Proscia’s Concentriq Dx platform, Siemens is entering the digital pathology market to satiate the rampant demand and expand its Enterprise Imaging offering with industry-leading technology to realize the full value of digital pathology operations. More...23 Mar 2022
Bioperfectus Partners with FIND to Increase COVID-19 Self-Testing Capacity in Low and Middle-Income Countries
Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China), a leading in-vitro diagnostics provider for infectious diseases, has partnered with FIND (Geneva, Switzerland), the global alliance for diagnostics, to accelerate the availability of affordable SARS-CoV-2 self-tests in low- and middle-income countries (LMICs). More...15 Mar 2022
Global Blood Collection Devices Market to Reach USD 7.8 Billion by 2026 Due to Increasing Incidence of Infectious Diseases
The global blood collection devices market is projected to register a CAGR of 6.0% from USD 5.7 billion in 2021 to USD 7.8 billion by 2026, driven primarily by the increasing incidence of infectious diseases, rising number of accidents & trauma cases, emergence of liquid biopsy tests, and demand for blood donations and blood components. However, the complexities of storage and shipping, and lack of skilled professionals are expected to restrain market growth during the forecast period. More...14 Mar 2022
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Clinical Informatics Platform
CLARION™
New
Steam Sterilizer
Hi Vac II Line
In Other News
AI-Powered Pathology Can Radically Enhance Diagnostic Accuracy and Treatment Selection
Consortium for Analytic Standardization in Immunohistochemistry (IHC) Launched to Improve Patient IHC Test Accuracy
Eli Lilly and Quanterix Collaborate to Advance Alzheimer's Blood-Based Biomarkers into Routine Clinical Use
Global Artificial Intelligence in Diagnostics Market to Surpass USD 5.6 Billion by 2027
Medix Biochemica Launches Refreshed and Expanding Brand to Reflect Growing IVD Products Portfolio
Registrations Open for 2022 AACC Annual Scientific Meeting & Clinical Lab Expo
Alcor Scientific Partners with Health Care Investor Water Street to Accelerate Expansion
Globe Scientific Unveils New Laboratory Glassware Line with Superior Packaging
AACC and Life Diagnostics Partner to Relaunch AACC Middle East
Becton Dickinson Acquires Clinical Flow Cytometry Firm Cytognos from Vitro S.A.
Global Cardiac POC Testing Devices Market Driven by Increasing Demand for Troponin Tests
Global Immunofluorescence Assay (IFA) Market to Surpass USD 4 Billion by 2028 Due to Growing Burden of Infectious Diseases
Illumina and Boehringer Ingelheim Partner to Develop Companion Diagnostics (CDx) for Cancer Treatment
Thermo Fisher and Oncocyte to Jointly Develop IVD Test Kits and Companion Diagnostic Tests in Precision Oncology
Global Coagulation Analyzers Market Driven by Growing Awareness About Timely Diagnosis of Blood Clots
Medlab Middle East to Reveal Latest Innovations and Technologies in Mobile Labs for COVID-19 Testing
Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders
Medlab Middle East to Return as Standalone Event in 2023
Global Clinical Immunoanalyzers Market to Be Driven by High Incidence of Chronic and Infectious Diseases
Global Point-of-Care Molecular Diagnostics Market to Be Driven by Rising Instances of Infectious Diseases
Quidel Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
Clinical Laboratory Tests Market Driven by Demand for Molecular, Pathological and Immunological Testing
Global In-Vitro Diagnostics (IVD) Market to Surpass USD 115 Billion in 2028 Due to Increasing COVID-19 Test Volumes
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
